Understanding Thyroid Nodule Malignancy Risks with Dr. Daniel Kwon

We are honored to have Dr. Daniel Kwon present "Malignancy Risk of Thyroid Nodules That Are Not Classifiable by the American Thyroid Association Ultrasound Risk Stratification System: A Systematic Review and Meta-Analysis." Dr. Franklin Tessler joins as the featured expert discussant. 0:00 Webinar 1:50 Dr. Kwon presents The study focuses on the rising incidence of thyroid nodules and cancer, concerns of overdiagnosis, and the use of ultrasound in risk stratification. It evaluates non-classifiable ATA nodules for malignancy risk, aiming to guide future management. 11:06 Analyzing Thyroid Nodule Studies The method involves analyzing studies from 2015 to 2022 on adults with thyroid nodules over 1 cm, using ATA URSS, excluding non-NC-ATA cases, and including 16 studies. 17:21 NC-ATA Nodules: Risk & Incidence NC-ATA nodules have a 7.78% incidence and 20.3% malignancy risk, with study type, design, and surgical pathology use significantly influencing risk estimates. 21:39 NC-ATA: Risk & Mgmt Strategies The study concludes that NC-ATA nodules are common with a 20% malignancy risk, supporting their significance and suggesting the need for FNA and further clarity through ultrasound patterns. 27:16 Dr. Tessler's Thoughts & Comments Dr. Tessler suggests revising ATA guidelines or using alternative methods to include all nodules, noting the need to reduce confusion caused by multiple systems and to develop a new risk stratification system. 44:49 Discussion with Q&A ** Check out our other programs! ** The THANC Guide https://thancguide.org/ TIRO: Thyroid Int'l Recommendations Online https://tiro.expert/ ** Follow us on Twitter! ** @thancfoundation - https://shorturl.at/puwS0 THANC on FB - https://shorturl.at/svNY4